MYC in breast tumor progression

Por Chen, Yinghua, Olopade, Olufunmilayo I
Publicado em 2008

Race, Ethnicity, and the Diagnosis of Breast Cancer

Por Daly, Bobby, Olopade, Olufunmilayo I.
Publicado no JAMA (2015)

MYC and Breast Cancer

Por Xu, Jinhua, Chen, Yinghua, Olopade, Olufunmilayo I.
Publicado em 2010

CYP2D6 Genotyping and Tamoxifen: An Unfinished Story in the Quest for Personalized Medicine

Por de Souza, Jonas A., Olopade, Olufunmilayo I.
Publicado em 2011

Heterogeneity in Hormone-Receptor Status and Survival Outcomes among Women with Synchronous and Metachronous Bilateral Breast Cancers

Por Baretta, Zora, Olopade, Olufunmilayo I., Huo, Dezheng
Publicado no Breast (2014)

rs2981582 is associated with FGFR2 expression in normal breast

Por Sun, Chang, Olopade, Olufunmilayo I, Di Rienzo, Anna
Publicado em 2010

Hidden Dangers: A Cryptic Exon Disrupts BRCA2 mRNA

Por Fackenthal, James D., Lee, Younghee, Olopade, Olufunmilayo I.
Publicado no Clin Cancer Res (2012)

“Why Take It If You Don't Have Anything?” Breast Cancer Risk Perceptions and Prevention Choices at a Public Hospital

Por Salant, Talya, Ganschow, Pamela S, Olopade, Olufunmilayo I, Lauderdale, Diane S
Publicado em 2006

Race and Subset Analyses in Clinical Trials: Time to Get Serious About Data Integration

Por Polite, Blase N., Sylvester, Brooke E., Olopade, Olufunmilayo I.
Publicado em 2011

Racial differences in a high-risk colorectal cancer referral population: a single-center experience

Por Gulden, Cassandra, Moss, Tovah, Olopade, Olufunmilayo I, Kupfer, Sonia
Publicado em 2011

Family History of Pancreatic Cancer in a High-Risk Cancer Clinic: Implications for Risk Assessment

Por Hall, Michael J., Dignam, James J., Olopade, Olufunmilayo I.
Publicado no J Genet Couns (2008)

Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013

Por Adedokun, Babatunde O., Olopade, Christopher O., Olopade, Olufunmilayo I.
Publicado no Glob Health Action (2016)

Breast cancer in women of African descent

Por Williams, Christopher Kwesi O., Olopade, Olufunmilayo I., Falkson, Carla I.
Publicado em 2006

Differential allelic expression of c.1568C>A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3′UTR

Por Sun, Chang, Southard, Catherine, Olopade, Olufunmilayo I., Di Rienzo, Anna
Publicado em 2011

The role of tumor-associated macrophages in breast cancer progression

Por OBEID, ELIAS, NANDA, RITA, FU, YANG-XIN, OLOPADE, OLUFUNMILAYO I.
Publicado em 2013

The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo

Por Wang, Pin-Yi, Huo, Dezheng, Sun, Chang, Olopade, Olufunmilayo I.
Publicado em 2013

Advances in Breast Cancer: Pathways to Personalized Medicine

Por Olopade, Olufunmilayo I., Grushko, Tatyana A., Nanda, Rita, Huo, Dezheng
Publicado no Clin Cancer Res (2008)

BRCA2 T2722R Is a Deleterious Allele That Causes Exon Skipping

Por Fackenthal, James D., Cartegni, Luca, Krainer, Adrian R., Olopade, Olufunmilayo I.
Publicado em 2002

Power Spectral Analysis of Mammographic Parenchymal Patterns for Breast Cancer Risk Assessment

Por Li, Hui, Giger, Maryellen L., Olopade, Olufunmilayo I., Chinander, Michael R.
Publicado em 2008

Novel germline PALB2 truncating mutations in African-American breast cancer patients

Por Zheng, Yonglan, Zhang, Jing, Niu, Qun, Huo, Dezheng, Olopade, Olufunmilayo I.
Publicado em 2011